Cargando…

Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi?

We present the case of a 19-year-old female with nasopharyngeal carcinoma, who received two courses of chemotherapy with 5-fluorouracil (5-FU) in combination with folic acid and cisplatin. Upon developing esophageal strictures in the course of her radiotherapy, she required total parenteral nutritio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosen, A., van Kuilenburg, A., Assmann, B., Kuhlen, M., Borkhardt, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177792/
https://www.ncbi.nlm.nih.gov/pubmed/21941485
http://dx.doi.org/10.1159/000328803
_version_ 1782212328350023680
author Rosen, A.
van Kuilenburg, A.
Assmann, B.
Kuhlen, M.
Borkhardt, A.
author_facet Rosen, A.
van Kuilenburg, A.
Assmann, B.
Kuhlen, M.
Borkhardt, A.
author_sort Rosen, A.
collection PubMed
description We present the case of a 19-year-old female with nasopharyngeal carcinoma, who received two courses of chemotherapy with 5-fluorouracil (5-FU) in combination with folic acid and cisplatin. Upon developing esophageal strictures in the course of her radiotherapy, she required total parenteral nutrition. In the course of therapy, the patient developed severe multisystem failure with encephalopathy, lactic acidosis, vegetative instability and neuropathy. The treatment with 5-FU can lead to severe toxicity due to enzyme deficiencies in the degradation of pyrimidines, but it can also lead to thiamine deficiency with the classic symptoms of beriberi. Beriberi is a rare disorder, usually attributed to malnutrition or alcoholism. 5-FU has been shown to induce thiamine depletion. Reduced food intake or total parenteral nutrition devoid of vitamin supplements may aggravate symptoms. We were unable to find a genetic cause for increased 5-FU toxicity in our patient, ruling out deficiencies of dihydropyrimidine dehydrogenase, dihydropyrimidinase or β-ureidopropionase and double-strand break repair deficits. We come to the conclusion that, even without any definable enzyme deficiency, treatment with 5-FU can lead to high toxicity due to thiamine deficiency if vitamin supplementation is not undertaken.
format Online
Article
Text
id pubmed-3177792
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-31777922011-09-22 Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi? Rosen, A. van Kuilenburg, A. Assmann, B. Kuhlen, M. Borkhardt, A. Case Rep Oncol Published: August 2011 We present the case of a 19-year-old female with nasopharyngeal carcinoma, who received two courses of chemotherapy with 5-fluorouracil (5-FU) in combination with folic acid and cisplatin. Upon developing esophageal strictures in the course of her radiotherapy, she required total parenteral nutrition. In the course of therapy, the patient developed severe multisystem failure with encephalopathy, lactic acidosis, vegetative instability and neuropathy. The treatment with 5-FU can lead to severe toxicity due to enzyme deficiencies in the degradation of pyrimidines, but it can also lead to thiamine deficiency with the classic symptoms of beriberi. Beriberi is a rare disorder, usually attributed to malnutrition or alcoholism. 5-FU has been shown to induce thiamine depletion. Reduced food intake or total parenteral nutrition devoid of vitamin supplements may aggravate symptoms. We were unable to find a genetic cause for increased 5-FU toxicity in our patient, ruling out deficiencies of dihydropyrimidine dehydrogenase, dihydropyrimidinase or β-ureidopropionase and double-strand break repair deficits. We come to the conclusion that, even without any definable enzyme deficiency, treatment with 5-FU can lead to high toxicity due to thiamine deficiency if vitamin supplementation is not undertaken. S. Karger AG 2011-08-10 /pmc/articles/PMC3177792/ /pubmed/21941485 http://dx.doi.org/10.1159/000328803 Text en Copyright © 2011 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: August 2011
Rosen, A.
van Kuilenburg, A.
Assmann, B.
Kuhlen, M.
Borkhardt, A.
Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi?
title Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi?
title_full Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi?
title_fullStr Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi?
title_full_unstemmed Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi?
title_short Severe Encephalopathy, Lactic Acidosis, Vegetative Instability and Neuropathy with 5-Fluorouracil Treatment – Pyrimidine Degradation Defect or Beriberi?
title_sort severe encephalopathy, lactic acidosis, vegetative instability and neuropathy with 5-fluorouracil treatment – pyrimidine degradation defect or beriberi?
topic Published: August 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177792/
https://www.ncbi.nlm.nih.gov/pubmed/21941485
http://dx.doi.org/10.1159/000328803
work_keys_str_mv AT rosena severeencephalopathylacticacidosisvegetativeinstabilityandneuropathywith5fluorouraciltreatmentpyrimidinedegradationdefectorberiberi
AT vankuilenburga severeencephalopathylacticacidosisvegetativeinstabilityandneuropathywith5fluorouraciltreatmentpyrimidinedegradationdefectorberiberi
AT assmannb severeencephalopathylacticacidosisvegetativeinstabilityandneuropathywith5fluorouraciltreatmentpyrimidinedegradationdefectorberiberi
AT kuhlenm severeencephalopathylacticacidosisvegetativeinstabilityandneuropathywith5fluorouraciltreatmentpyrimidinedegradationdefectorberiberi
AT borkhardta severeencephalopathylacticacidosisvegetativeinstabilityandneuropathywith5fluorouraciltreatmentpyrimidinedegradationdefectorberiberi